BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

GP1BB identified as NASH target

Claire Quang
April 30, 2019 8:14 PM UTC

INDICATION: Non-alcoholic steatohepatitis (NASH)...

BCIQ Company Profiles

Helmholtz Zentrum Muenchen GmbH

University of Zurich

BCIQ Target Profiles

Glycoprotein Ib (platelet) beta polypeptide (GP1BB) (CD42c)

BCIQ Company Profiles

Helmholtz Zentrum Muenchen GmbH

University of Zurich

BCIQ Target Profiles

Glycoprotein Ib (platelet) beta polypeptide (GP1BB) (CD42c)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2026 BioCentury Inc. All Rights Reserved.
Copyright © 2026 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS